UBC12 Antibodies

Santa Cruz Biotechnology delivers a wide array of UBC12 monoclonal antibodies for research focused on understanding UBC12's role in cellular processes. UBC12 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UBC12, a member of the ubiquitin-conjugating enzyme family, plays a critical role in the ubiquitin-proteasome system, which is essential for protein degradation and regulation of various cellular functions. UBC12 is involved in the modification of target proteins through ubiquitination, influencing processes such as cell cycle regulation, DNA repair, and signal transduction. Research has shown that UBC12 activity significantly impacts cellular homeostasis and protein regulation pathways. Understanding UBC12 function is vital for elucidating its implications in various diseases, including cancer and neurodegenerative disorders. Investigating UBC12's molecular mechanisms can provide valuable insights into disease development and potential therapeutic strategies. Current research continues to uncover new roles for UBC12 in cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of UBC12's role in health and disease.